While pharmaceutical executives raise valid concerns about the lack of detailed implementation plans for the “Most Favored ...

(Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and ...

Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the ...

Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Eli Lilly (NYSE:LLY ... The latest executive order on drug prices by President Donald Trump has only added to its woes, or has it? The order signed on May 12 aims to align U.S. drug prices ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...